Blood Group B May Reduce Risk of Rebleeding in Patients With Upper Gastrointestinal Haemorrhage due to Peptic Ulcer Disease

Risk stratification tools for the prediction of complications in patients with upper gastrointestinal haemorrhage are crucial for appropriate management. Blood group status has been associated with the risk of bleeding, thrombosis and risk of peptic ulcer disease (PUD). We assessed the influence of blood group status on rebleeding and other complications in 699 patients with PUD bleeding. Blood group B was associated with reduced risk in the composite outcome of rebleeding, need for surgery or embolisation and mortality (OR 0.15, 95% CI 0.04-0.63, p = 0.009). Blood group B was protective against rebleeding compared to non-blood group B (OR 0.20, 95% CI 0.05-0.84, p = 0.028).

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2025-01-09
DOI
https://doi.org/10.1111/apt.18485
Citations
1
Primary Topic
Gastrointestinal Bleeding Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Blood Group B May Reduce Risk of Rebleeding in Patients With Upper Gastrointestinal Haemorrhage due to Peptic Ulcer Disease

Prahlad Ho, Mark Tacey, Ray Boyapati, Peter G. Gibson et al.
1 citations
Alimentary Pharmacology & Therapeutics
Gastrointestinal Bleeding Diagnosis and Treatment
1.81
article

Blood Group B May Reduce Risk of Rebleeding in Patients With Upper Gastrointestinal Haemorrhage due to Peptic Ulcer Disease

Prahlad Ho, Mark Tacey, Ray Boyapati, Peter G. Gibson, Mayur Garg, Ross Apostolov, Anuk Kruavit, Krishneel Dutt, N.‐Y. Lee, Lynna Chen, Bei Ye, Mani Suleiman, Sim Ong, Sarah Taylor
article en
1 citations

Abstract

Risk stratification tools for the prediction of complications in patients with upper gastrointestinal haemorrhage are crucial for appropriate management. Blood group status has been associated with the risk of bleeding, thrombosis and risk of peptic ulcer disease (PUD). We assessed the influence of blood group status on rebleeding and other complications in 699 patients with PUD bleeding. Blood group B was associated with reduced risk in the composite outcome of rebleeding, need for surgery or embolisation and mortality (OR 0.15, 95% CI 0.04-0.63, p = 0.009). Blood group B was protective against rebleeding compared to non-blood group B (OR 0.20, 95% CI 0.05-0.84, p = 0.028).

Alimentary Pharmacology & TherapeuticsVol. 61(4)
The University of Melbourne (AU), Northern Health (AU), Eastern Health (AU), Monash Health (AU), Melbourne Health (AU), Austin Health (AU), Monash University (AU)
Good health and well-being
Openalex Percentile: Top 21%
Gastrointestinal Bleeding Diagnosis and Treatment
1.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Blood Group B May Reduce Risk of Rebleeding in Patients With Upper Gastrointestinal Haemorrhage due to Peptic Ulcer Disease — Prahlad Ho, Mark Tacey, et al. · Alimentary Pharmacology & Therapeutics (2025) | TGRS Research Map | TGRS